A Novel Use of Olaparib for the Treatment of Metastatic Castration-Recurrent Prostate Cancer-Reference-Cited by-同舟云学术

A Novel Use of Olaparib for the Treatment of Metastatic Castration-Recurrent Prostate Cancer

Published:2017-11 Issue:11 Volume:37 Page:1406-1414
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Martin Grace A.¹,Chen Adrienne H.¹,Parikh Kinjal¹

Affiliation:

1. Division of Pharmacy; The University of Texas MD Anderson Cancer Center; Houston Texas

Publisher

Wiley

Subject

Pharmacology (medical)

Reference55 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Role of the androgen-androgen receptor axis in the treatment resistance of advanced prostate cancer: from androgen-dependent to castration resistant and further;Fujimoto;J UOEH,2016

3. Metastatic castration-resistant prostate cancer: targeting the mechanisms of resistance to abiraterone acetate and enzalutamide;Modena;Expert Rev Anticancer Ther,2015

4. DNA-repair defects and olaparib in metastatic prostate cancer;Mateo;N Engl J Med,2015

5. National Comprehensive Cancer Network Prostate Cancer NCCN Evidence Blocks (Version 3.2016) https://www.nccn.org/professionals/physician_gls/pdf/prostate_blocks.pdf

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study);European Journal of Nuclear Medicine and Molecular Imaging;2024-07-15

2. ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1;Scientific Reports;2023-07-31

3. GLIDR promotes the aggressiveness progression of prostate cancer cells by sponging miR-128–3p;Pathology - Research and Practice;2023-02

4. Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators;Asian Journal of Andrology;2023

5. BRCA2 gene mutation in cancer;Medicine;2022-11-11